SPEF2 and bladder transitional cell carcinoma: Investigating the role of novel CTAs, such as SPEF1 and SPEF2, in BLCA within the immune system may provide insights into novel immunotherapeutic approaches, such as the use of autologous dendritic cells pulsed with SPEF1 and SPEF2 peptides.